Clinical trial C101
Open, non-controlled, multicenter, first-in-human study for the evaluation of the safety, pharmacokinetics and preliminary antitumor activity of GM102 in patients with advanced pretreated gynecological cancer
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Gamamabs Pharma |
EudraCT Identifier | 2015-004252-22 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02978755 |
Inclusion criteria | Any line RECIST 1.1 |
Last update |